P rostate cancer is one of the most common cancers among men, and it is the sixth leading cause of cancer-related mortality in men worldwide. [1] [2] [3] [4] It has become a significant health problem in both developed and developing countries. 2, 4 The incidence rate of prostate cancer differs from country to country, and the proportion of cases vary by more than 25-fold globally. 5 According to the American Cancer Society, in 2008 an estimated 903,500 new cases of prostate cancer were reported among men internationally, while the number of deaths was 258,400. 4, 5 Prostate cancer is the second leading cause of death among men in the United States, 1 and will influence one in six males during their life span. In 2013, it is estimated that 238,590 new cases will be detected and 29,720 men will die from prostate cancer. 6 The burden of prostate cancer has increased in Europe, with an estimated 379,000 new cases and 94,000 deaths reported in 2008. 7 In addition, mortality rates continue to increase in African people, and decrease in the Asian population. 4, 7 In Saudi Arabia, the International Agency for Research on Cancer (IARC) estimated that the age-standardised incidence rate (ASIR) for prostate cancer was 7.7 per 100,000 men in 2008, and the age-standardised mortality rate (ASMR) was 5.1 per 100,000 men. 7 Furthermore, the registry of the King Faisal Specialist Hospital and Research Centre (2011) recorded 1213 cases (1.7%) of prostate cancer admitted to the hospital during the years 1975-2011. 8 In 2008, the Saudi Cancer Registry (SCR) reported that prostate cancer ranked sixth in cancer incidence among Saudi men. 9 The age standardized incidence rate of prostate cancer in Saudi Arabia is very low in comparison to Arab Gulf and European countries. For example, in 2008, the reported ASIRs for Qatar, Bahrain, Kuwait, and United Arab Emirates were higher than Saudi Arabia at 15, 13.3, 11.6 and 9.6, respectively.
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Despite lacking information about prostate cancer in Saudi Arabia, except for the SCR reports, we have attempted to study the incidence of prostate cancer in different regions of Saudi Arabia during the years [2001] [2002] [2003] [2004] [2005] [2006] [2007] [2008] . The objectives of this study are to investigate and describe the distribution of prostate cancer in terms of the characteristics of person, place and time among Saudi men. 10 
MATERIALS AND METHODS
We conducted a retrospective descriptive epidemiological study of all Saudi men prostate cancer cases diagnosed between January 2001 and December 2008. Data for cancer in Saudi Arabia are publicly available and easily accessible. The data sources for this study were made possible by the SCR, a population-based registry established in 1994 by the Ministry of Health in Saudi Arabia. The data cannot be obtained directly from the SCR, except through published reports. There were no available data from 1994 to 2000, and the latest published report of the SCR was in 2008. Other cancer reports have been published by the King Faisal Specialist Hospital and Research Center, which is a hospital-based registry. We were therefore unable to use them for a general analysis of the Saudi male population.
Since its establishment, the SCR has been providing reports on the pattern of cancer in Saudi Arabia with a primary objective of defining the populationbased incidence of the disease. Based on these data, there are currently comprehensive reports for 13 administrative regions from 2001 to 2008 that outline the frequency and percentage of cases, the CIR and the ASIR adjusted by the provinces of Saudi Arabia and the year of diagnosis for each case. This study was conducted using these reports from the Saudi Cancer Registry with the aim of presenting the descriptive epidemiology of prostate cancer in Saudi Arabia.
For data analysis, we used the Statistical Package for the Social Sciences version 20.0 (SPSS). The descriptive analysis of the epidemiological data was performed by calculating the overall percentage, the CIR and the ASIR adjusted by the age group, region and year of diagnosis. The percentage was calculated by adding the number of prostate cancer cases and then dividing that number by the total number of male cancer cases. Furthermore, analysis of variance test (ANOVA) was performed to determine any significant differences among the regions and years of diagnosis. 11 In addition, the linear regression model that investigates the strength of the association between independent variables and an outcome was applied to predict the annual CIR and the ASIR for prostate cancer among Saudi men. 12 In addition, the Poisson regression model was conducted to calculate the incidence rate ratio of prostate cancer cases in each region of Saudi Arabia. (Table 1) . This is a particularly important rate when making comparisons between different populations with respect to the age structure. (Table 2) and (Figure 1c and d) . The age groups reported correspond to 00-44, 45-59, 60-74, and over 75 years. According to the overall numbers and percentages, the age groups that recorded the highest affected by prostate cancer were men aged 60-74 years, with 111 cases, representing 50.7% of the total number of prostate cancer cases, followed by those over 75 years, with 80 cases, representing 37.5%. The younger group aged 00-44 years recorded the lowest overall number and percentage with two cases, representing less than 1% of the total number of prostate cancer cases, followed by men aged 45-59 years with 24 cases, representing 10.8%.
The CIRs adjusted by year of diagnosis from 2001 to 2008 per 100,000 men indicate a steady increase of prostate cancer among men in Saudi Arabia. According to Table 3 and Figure 2a , a CIR of 1.9 (95% CI, 1.4 to 2.4) per 100,000 men was estimated in 2001, and a CIR of 2.9 (95% CI, 2.1 to 3.7) per 100,000 men was estimated in 2008. In 2005, the CIR of 3.1 (95% CI, 2.3 to 3.9) per 100,000 men was the highest rate, but was not statistically significant compared to the other years: F(7, 96) = 0.76, p > 0.05. However, this figure dropped by 0.2% in 2008. Based on the linear regression model, the equation for a straight line to predict the annual CIR of prostate cancer in Saudi Arabia is 1.53 + (0.094 · Years), and the incidence rate of prostate cancer increased by a predicted average of 0.094 per 100,000 Saudi men per year.
The overall CIR of prostate cancer adjusted by the regions of Saudi Arabia from 2001 to 2008 per 100,000 men was calculated from the SCR, as shown in Table 4 and Figure 2b The eastern region of Saudi Arabia had the highest overall CIR for prostate cancer at 3.5 (95% CI, 3.1 to 3.9) per 100,000 men, followed by Riyadh at 3.0 (95% CI, 2.6 to 3.5) and Makkah at There are no significant differences between years of diagnosis p-value > 0.05. . Therefore, the analysis of variance test revealed that the incidence rates of prostate cancer were significantly higher for these regions compared to other parts of Saudi Arabia: F(12, 91) = 8.483, p < 0.001. Furthermore, Jizan (95% CI, 0.8 to 1.4), and Najran (95% CI, 0.4 to 1.9) had the lowest average CIRs for prostate cancer among Saudi men at 1.1 and 1.2, respectively. However, the figures for these regions were generally in agreement with increasing or decreasing ASIR. The world age-standardised incidence rate of prostate cancer per 100,000 men, adjusted for the region and the year of diagnosis, suggests a similar trend to that seen for the CIR from 2001 to 2008 (Figure 2c  and d ). There was a slight increase in the cases of prostate cancer diagnosed between 2001 and 2008, with the highest ASIR of 6.2 reported in 2005 (95% CI, 4.5 to 7.9), followed by a slight decrease in the ASIR to 5.7 in 2008 (95% CI, 4.0 to 7.4), according to reports released by the SCR. However, the equation for the straight line to predict the annual ASIR of prostate cancer in Saudi Arabia is 2.97 + (0.182 · Years), and the ASIR of prostate cancer increased by a predicted average of 0.182 per 100,000 Saudi men per year. Similarly, the eastern part of Saudi Arabia had the highest mean ASIR at 10.1 (95% CI, 8.6 to 11.6), followed by Riyadh at 7.1 (95% CI, 5.7 to 8.5) and Makkah at 5.2 (95% CI, 3.9 to 6.6). Therefore, the analysis of variance was statistically significant for these regions compared to other provinces of Saudi Arabia: F(12, 91) = 18.693, p < 0.001. Jizan (95% CI, 0.7 to 2.2) and Najran (95% CI, 0.7 to 3.2) had the lowest mean ASIRs at 1.4 and 2.0, respectively. The Poisson regression model was conducted to calculate the incidence rate ratio (IRR) of prostate cancer cases in different regions of Saudi Arabia. The model was statistically significant: LR v (Table 6) Our results also confirm that the regions of Jizan and Najran have the lowest values in the average CIR and ASIR. The age group most affected by prostate cancer in Saudi Arabia and in other developed countries is of men above 65 years of age. 15, 16 Despite the extensive use of prostate specific antigen (PSA) screening for early detection of the presence of the disease in both younger and older men, incidence rates in men older than 65 years remain high. 16 However, in some clinical trial studies, PSA has proved to be a major limitation for identifying the true cases of prostate cancer, with false positive results recorded due to lack of sensitivity of the test. 17, 18 Other studies have specified that the PSA screening test decreased 
